| HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways F Guo, Q Zhao, M Sheraz, J Cheng, Y Qi, Q Su, A Cuconati, L Wei, Y Du, ... PLoS pathogens 13 (9), e1006658, 2017 | 125 | 2017 |
| DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA L Tang, M Sheraz, M McGrane, J Chang, JT Guo PLoS Pathogens 15 (4), e1007742, 2019 | 80 | 2019 |
| Cellular DNA topoisomerases are required for the synthesis of hepatitis B virus covalently closed circular DNA M Sheraz, J Cheng, L Tang, J Chang, JT Guo Journal of Virology 93 (11), 10.1128/jvi. 02230-18, 2019 | 74 | 2019 |
| Activation of stimulator of interferon genes in hepatocytes suppresses the replication of hepatitis B virus F Guo, L Tang, S Shu, M Sehgal, M Sheraz, B Liu, Q Zhao, J Cheng, ... Antimicrobial agents and chemotherapy 61 (10), 10.1128/aac. 00771-17, 2017 | 74 | 2017 |
| A mini-review on the impact of COVID 19 on vital organs MD Shah, AS Sumeh, M Sheraz, MS Kavitha, BAV Maran, KF Rodrigues Biomedicine & pharmacotherapy 143, 112158, 2021 | 38 | 2021 |
| Interferon alpha induces multiple cellular proteins that coordinately suppress hepadnaviral covalently closed circular DNA transcription J Cheng, Q Zhao, Y Zhou, L Tang, M Sheraz, J Chang, JT Guo Journal of Virology 94 (17), 10.1128/jvi. 00442-20, 2020 | 27 | 2020 |
| Computational analysis to predict functional role of hsa-miR-3065-3p as an antiviral therapeutic agent for treatment of triple infections: HCV, HIV-1, and HBV A Khokha, S Noorali, M Sheraz, K Mahalingham, DG Pace, MR Khanani, ... Libyan Journal of Medicine 7 (1), 2012 | 21 | 2012 |
| Potential utility of GB virus type C as a preventive vaccine for HIV-1 O Bagasra, AU Bagasra, M Sheraz, DG Pace Expert review of vaccines 11 (3), 335-347, 2012 | 16 | 2012 |
| Hepatitis G virus or GBV-C: a natural anti-HIV interfering virus O Bagasra, M Sheraz, DG Pace Viruses: Essential Agents of Life, 363-388, 2012 | 5 | 2012 |
| Effec t of Differentially Expressed MicroRNAs 602 and 323-5p on Hepatitis C Viru s Genotype 1b Viral Load in Infected Liver Cells S Noorali, M Sheraz, SS Tisdale, SS Dallas, ML Simons J Infect Dis Ther 2 (138), 2332-0877.1000138, 2014 | 4 | 2014 |
| Use of Flaviviral genetic fragments as a potential prevention strategy for HIV-1 Silencing M Sheraz, M Kanak, M Hasan, R Bhattarai, K Mahalingam, LA Sealey, ... The Journal of Infection in Developing Countries 10 (08), 870-879, 2016 | 2 | 2016 |
| Detection of anthrax toxin genetic sequences by the solid phase oligo-probes KC Addanki, M Sheraz, K Knight, K Williams, DG Pace, O Bagasra Indian Journal of Medical Microbiology 29 (4), 372-378, 2011 | 1 | 2011 |
| Discovery of C-Linked Nucleoside Analogues with Antiviral Activity against SARS-CoV-2 EF Mesaros, BJ Dugan, M Gao, M Sheraz, K McGovern-Gooch, F Xu, ... ACS Infectious Diseases, 2024 | | 2024 |
| Preclinical Antiviral and Safety Profiling of the HBV RNA Destabilizer AB-161 AM Lam, RR Dugyala, M Sheraz, F Liu, EP Thi, IE Graves, A Cuconati, ... Viruses 16 (3), 323, 2024 | | 2024 |
| Identification of Host Proteins Required for Hepatitis B Virus Covalently Closed Circular DNA Biosynthesis by a Chemogenetic Approach M Sheraz Drexel University, 2019 | | 2019 |
| Computational analysis to predict functional role of hsa-miR-3065-3p as an antiviral therapeutic agent for treatment of triple infections: HCV, HIV-1, and HBV. AK Ambreen Khokhar, S Noorali, M Sheraz, K Mahalingham, DG Pace, ... | | 2012 |
| SARS-CoV-2 Mpro Inhibitor with Pan-coronavirus Activity N Mani, D Gotchev, KR McGovern-Gooch, A Ardzinski, A Cuconati, ... | | |
